Skip to content

Clinical Application of Autologous Mitochondria Transplantation for Improving Oocyte Quality.

A Pilot Study of the Effect of Autologous Mitochondria Transplantation in Assisted Reproductive Technology Clinical Outcome.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03639506
Enrollment
50
Registered
2018-08-21
Start date
2018-09-30
Completion date
2021-09-30
Last updated
2018-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Repetition Failure

Keywords

repetition failure, autologous mitochondria transplantation, embryo quality, live birth rate

Brief summary

Embryo quality was ranked as one of the most important predictors in determining the success of implantation, while clinically some patients may experience repeated IVF failure due to persistent poor embryo quality.Mitochondria, as the energy factory, is confirmed being a hallmark of quality and developmental potential of human oocytes, and decreased mitochondria copy number was reported to be associated with oocyte aging and dysfunctional mitochondria would be expected to influence the late stages of oocyte maturation and early embryogenesis.The objective of this study is to evaluate the effect of mitochondria transfer from bone marrow mesenchymal stem cell on the quality of oocyte.

Detailed description

This study is a pilot study to investigate the effect of autologous mitochondria transplantation for improving oocyte quality. Design: randomized controlled trial. Setting: Assisted reproductive technologies unit. Patients: patients who is in accordance with the inclusion criteria, and not meet the exclusion criteria, who had repeated IVF treatment from Sep 2018 to Sep 2021. Intervention: The comparison was made between mitochondria transfer(MIT) group and the control group, both groups are conducted with the GnRH-a super-long protocol for IVF treatment. MIT group injects autologous mitochondria from bone mesenchymal stem cells into oocyte. Main outcome measures: The primary outcome of the study is live birth rate. The secondary outcomes were clinical pregnancy rate, number of oocytes retrieved, fertility rate, normal fertilization rate, rate of transferable embryo and good quality embryo rate.

Interventions

inject autologous mitochondria from bone marrow mesenchymal stem cells into oocyte

COMBINATION_PRODUCTautologous mitochondria from bone marrow mesenchymal stem cells into oocyte as well as intracytoplasmic sperm injection (ICSI)

autologous mitochondria transplantation

intracytoplasmic sperm injection (ICSI)

Sponsors

Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 43 Years
Healthy volunteers
Yes

Inclusion criteria

1. Women age \>20 years and \<43 years. 2. Anti-müllerian hormone(AMH) level ≥1.1 ng/ml. 3. Previous failed transfer cycle ≥2. 4. BMI\>18kg/m2 and \<25kg/m2. 5. Written informed consent.

Exclusion criteria

1. Abnormal uterine development, endometrial adhesion or previous endometrial dysplasia (\<7mm) 2. Other medical diseases that cannot be pregnant. 3. Complicated with adenomyosis, endometriosis confirmed by surgery, ovarian endometriosis cyst ≥2 cm by ultrasound, all kind of malignant tumors or precancerous disease. 4. Untreated hydrosalpinx. 5. The man has definite factors that affect the quality of the embryo, such as persistent abnormal DNA fragment rate (\>30%) and non-obstructive spermatozoa. 6. Intracytoplasmic sperm injection with donor. Eliminate or falls off Criteria: 1.The number of retrieved oocytes \<6.

Design outcomes

Primary

MeasureTime frameDescription
live birth rate2-3yearsnumber of live birth/ transferred cycle.Compare the live birth rate between the two groups with SPSS 20.0.

Secondary

MeasureTime frameDescription
clinical pregnancy rate2-3yearsClinical pregnancy means pregnancy sac is seen intrauterine under ultrasound 7 weeks after embryo transferred. Clinical pregnancy rate(%): number of clinical pregnancy/transferred cycle.Compare the clinical pregnancy rate between the two group with SPSS 20.0.
number of oocytes retrieved2-3yearsCompare the number of oocytes retrieved between the two group with SPSS 20.0.
fertility rate2-3yearsFertility rate(%): number of oocyte fertilized/ number of oocytes retrieved.Compare the fertility rate between the two group with SPSS 20.0.
normal fertility rate2-3yearsNormal fertility rate(%): number of oocyte normally fertilized/ number of oocytes retrieved. Compare the normal fertility rate between the two group with SPSS 20.0.
good quality embryo rate2-3yearsCleavage embryo grades 1 or 2 with 6-10 blastomeres were considered good quality embryos. Good quality embryo rate(%): number of good quality embryo/number of fertilized oocytes.Compare the good quality embryo rate between the two group with SPSS 20.0.

Contacts

Primary ContactXiaoyan Liang, MD. Prof.
lxyzy@263.net020-38048013

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 15, 2026